Sectors

SMTI
Sanara MedTech Inc.
34.68
2 x 24.77
1 x 34.57
bid
ask
+
0.11
0.32%
03:07 PM
timesize
Ytd48.52%
1y3.03%
34.51
day range
34.68
16.05
52 week range
35.95
Open34.59Prev Close34.57Low34.51High34.68Mkt Cap318.64M
Vol147.73KAvg Vol213.89KEPS-0.04P/EN/AForward P/E-29.15
Beta1.13Short Ratio5.88Inst. Own9.40%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1150-d Avg28.82200-d Avg22.921yr Est44.00

SMTI News

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
gurufocus.com
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Sanara MedTech Inc. (NAS

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
zacks.com
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech Inc. (SMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Co

benzinga.com
Sanara MedTech Q2 EPS $(0.05) Misses $0.02 Estimate, Sales $28.137M Miss $28.950M Estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.05) per share which missed the analyst

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
globenewswire.com
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” t

The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—FBRX, LXFR, SMTI, and MKTX
globenewswire.com
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—FBRX,

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX
gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI,

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI,

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—FBRX, LXFR, SMTI, and MKTX
globenewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—FBRX, LXFR, SMTI, a

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess

BALA CYNWYD, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
prnewswire.com
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
businesswire.com
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)
prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASD

NEW YORK, July 30, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Ass

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess

BALA CYNWYD, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

benzinga.com
HC Wainwright & Co. Downgrades Sanara MedTech to Neutral, Lowers Price Target to $35

HC Wainwright & Co. analyst Yi Chen downgrades Sanara MedTech (NASDAQ:SMTI) from Buy to Neutr

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
gurufocus.com
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for

MILWAUKEE, July 30, 2026 /PRNewswire/ -- Ademi LLP is investigating Sanara (Nasdaq: SMTI) for possib

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

benzinga.com
MIMEDX Acquires Sanara MedTech For ~$350M

Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgica

MIMEDX to Acquire Sanara MedTech
globenewswire.com
MIMEDX to Acquire Sanara MedTech

Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgica

benzinga.com
Sanara Medtech Ends Previously Announced Services Agreement With The Catalyst Group; Not Obliged To

https://www.sec.gov/ix?doc=/Archives/edgar/data/714256/000149315226027274/form8-k.htm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
gurufocus.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Transcript: Sanara MedTech Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call

benzinga.com
Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M vs $117.300M Est

Sanara MedTech (NASDAQ:SMTI) affirms FY2026 sales outlook from $116.000 million-$121.000 million to

benzinga.com
Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly earnings of $0.05 per share which beat the analyst c

benzinga.com
Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32

Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ:SMTI) with a Buy

benzinga.com
CORRECTION: Sanara MedTech Q4 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $27.546M Beat $27.400M Est

Sanara MedTech (NASDAQ:SMTI) reported quarterly earnings of $0.09 per share which missed the analyst

Earnings Scheduled For March 24, 2026
benzinga.com
Earnings Scheduled For March 24, 2026

benzinga.com
Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M

Sanara MedTech (NASDAQ:SMTI) affirms FY2026 sales outlook from $116.000 million-$121.000 million to

benzinga.com
Sanara MedTech Announces Publication Of Peer-Reviewed Study Evaluating Economic And Clinical Value O

Study demonstrates cost savings and improved health outcomes associated with the use of CellerateRX®

benzinga.com
HC Wainwright & Co. Reiterates Buy on Sanara MedTech, Maintains $36 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Sanara MedTech (NASDAQ:SMTI) with a Buy and ma

benzinga.com
Sanara MedTech Expects FY25 Revenue To Be $102.7M-$103.2M, Up ~ 19%, Compared To $86.7M In FY24

Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we,&#34

benzinga.com
Sanara MedTech Expects Q4 Revenue To Be $27.2M-$27.7M, Up ~3%-5%, Compared To $26.3M In Q4 Of 2024

Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we,&#34

benzinga.com
Sanara MedTech's BIASURGE Advanced Surgical Solution Product Receives Innovative Technology Contract

Contract awarded for products that bring improvement to the healthcare industryFORT WORTH, TX, Jan.

benzinga.com
Sanara MedTech And Biomimetic Innovations Advance Strategic Alliance; Sanara Reaffirms Plans To Laun

Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic&#

Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com
HC Wainwright & Co. Maintains Buy on Sanara MedTech, Lowers Price Target to $36

HC Wainwright & Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:SMTI) with a Buy and low

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025

benzinga.com
Earnings Scheduled For August 13, 2025

Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

benzinga.com
Earnings Scheduled For May 14, 2025

benzinga.com
Earnings Scheduled For March 25, 2025

benzinga.com
Earnings Scheduled For March 25, 2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly lo

benzinga.com
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

benzinga.com
Earnings Scheduled For August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

benzinga.com
Earnings Scheduled For May 15, 2023

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings f